Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Plasmodium falciparum | nicotinate phosphoribosyltransferase, putative | 0.0064 | 0.0862 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0035 | 0.0271 | 0.0407 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Loa Loa (eye worm) | pre-B cell enhancing factor | 0.0345 | 0.6658 | 1 |
Brugia malayi | Pre-B cell enhancing factor precursor | 0.0345 | 0.6658 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Schistosoma mansoni | nicotinate phosphoribosyltransferase | 0.0064 | 0.0862 | 0.0926 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0035 | 0.0271 | 0.0407 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Mycobacterium tuberculosis | Nicotinic acid phosphoribosyltransferase PncB1 | 0.0064 | 0.0862 | 0.5 |
Trypanosoma cruzi | nicotinate phosphoribosyltransferase, putative | 0.0064 | 0.0862 | 0.2019 |
Schistosoma mansoni | nicotinate phosphoribosyltransferase related pre-B cell enhancing factor | 0.0345 | 0.6658 | 1 |
Mycobacterium tuberculosis | Nicotinic acid phosphoribosyltransferase PncB2 | 0.0064 | 0.0862 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0035 | 0.0271 | 0.314 |
Schistosoma mansoni | nicotinate phosphoribosyltransferase related pre-B cell enhancing factor | 0.0064 | 0.0862 | 0.0926 |
Echinococcus multilocularis | nicotinamide phosphoribosyltransferase | 0.0345 | 0.6658 | 0.6565 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.0507 | 1 | 1 |
Leishmania major | nicotinate phosphoribosyltransferase, putative | 0.0064 | 0.0862 | 0.1927 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0177 | 0.32 | 1 |
Echinococcus granulosus | nicotinamide phosphoribosyltransferase | 0.0345 | 0.6658 | 0.6565 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0035 | 0.0271 | 0.314 |
Treponema pallidum | nicotinate phosphoribosyltransferase | 0.0064 | 0.0862 | 0.5 |
Trichomonas vaginalis | nicotinate phosphoribosyltransferase, putative | 0.0064 | 0.0862 | 1 |
Giardia lamblia | GTOR | 0.0035 | 0.0271 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Leishmania major | hypothetical protein, conserved | 0.0184 | 0.334 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0035 | 0.0271 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trypanosoma brucei | nicotinate phosphoribosyltransferase, putative | 0.0064 | 0.0862 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Entamoeba histolytica | nicotinate phosphoribosyltransferase, putative | 0.0064 | 0.0862 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.0271 | 0.314 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
clogP | = 6.81 | Calculated partition coefficient (clogP) | ChEMBL. | 7650681 |
ED50 (functional) | = 7.4 mg kg-1 | In vivo antifungal activity administered intraperitoneally against Candida albicans infections in mice. | ChEMBL. | 7650681 |
Inhibition (binding) | = 80.2 % | In vitro inhibition of glucan synthase obtained from C. albicans at a concentration of 10 ug/mL. | ChEMBL. | 7650681 |
MIC (functional) | = 0.02 ug ml-1 | Antifungal activity against Candida albicans | ChEMBL. | 7650681 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.